Search Results 1441-1450 of 19400 for hemoglobin

1. Mannitol-Based Solutions in the Quantification of Visceral Hypersensitivity - Mayo Clinic

   Presence of documented pseudo-obstruction, diabetes mellitus with a hemoglobin A1c of more than or equal to 8, scleroderma, slow transit constipation and ...

2. A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433 - Mayo Clinic

   Hemoglobin < 8 g/dL. Enrollment in another interventional clinical study while participating in this study. For Substudy 3 only: Total SES-CD > 4 and/or ...

3. Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube Cancer - Mayo Clinic

   Hemoglobin (Hgb) > 9.0 mg/dl; Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2; Ability to provide informed written consent; Life ...

4. A Study of TNB-383B in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   hemoglobin ≥ 8.0 g/dL;; Transfusion and / or growth factor support is permitted prior to assessment, but neutrophils, platelets, and hemoglobin must be ...

5. A Study to Evaluate TVB-2640 and Trastuzumab Plus Paclitaxel or Endocrine Therapy for Treating Patients with HER2 Positive Advanced Breast Cancer - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL;; Absolute neutrophil count (ANC) ≥ 1500/mm^3; Platelet count; ≥ 100,000/mm^3;; Direct bilirubin ≤ 1.5 x ULN;; Aspartate transaminase ...

6. A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers - Mayo Clinic

   Participation eligibility · Hemoglobin ≥ 8 g/dL; · Absolute neutrophil count ≥ 1000/μL; · Platelet count ≥ 75,000/μL (≥ 30,000/μL if bone marrow plasma cells ...

7. Autologous DC Vaccine For RRP Patients - Mayo Clinic

   Hemoglobin ≥ 8.5 g/dL; Lymphocytes ≥ 0.3 x 109 /L; Total bilirubin ≤ 2 x upper limit of normal (ULN), unless patient has a documented history of Gilbert's ...

8. Quanta Home Run Trial - Mayo Clinic

   Active, life-threatening, rheumatologic disease. 11. Hematocrit less than 28% at enrollment 12. Hemoglobin less than 9 g/dL at enrollment 13. Suffering from ...

9. Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma - Mayo Clinic

   Hemoglobin >= 8.0 g/dL; Diagnosis of symptomatic MM; Measurable disease of multiple myeloma at the time of baseline values for disease assessment as defined ...

10. A Study to Evaluate Abemaciclib to Treat Advanced Bone and Soft Tissue Sarcoma Identified as Having CDK Pathway Alteration - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dL. Patients may receive erythrocyte transfusions to achieve this hemoglobin level at the discretion of the investigator. Initial ...